Evofem Biosciences, Inc. short interest in 2022
In 2022, Evofem Biosciences, Inc.'s disclosed short interest ran from 16.41% of shares outstanding on 14 Jan 2022 to 10.62% on 29 Apr 2022, a change of -5.79 percentage points. The year's high was 16.41% on 14 Jan 2022 and its low 10.31% on 31 Mar 2022, averaging 12.87% across 8 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.35 days on 15 Feb 2022. Full history: Evofem Biosciences, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022
2022 in figures
- Start of year
- 16.41% (14 Jan 2022)
- End of year
- 10.62% (29 Apr 2022)
- Change
- -5.79 pp
- High
- 16.41% (14 Jan 2022)
- Low
- 10.31% (31 Mar 2022)
- Average
- 12.87%
- Highest days to cover
- 13.35 (15 Feb 2022)
- SEC filings marked
- 7
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 16.41% | 3.24 | |
| 31 Jan 2022 | 15.88% | 7.19 | results (8-K) |
| 15 Feb 2022 | 15.72% | 13.35 | |
| 28 Feb 2022 | 12.21% | 6.60 | |
| 15 Mar 2022 | 11.23% | 7.75 | results (8-K), 10-K filed |
| 31 Mar 2022 | 10.31% | 8.10 | |
| 14 Apr 2022 | 10.60% | 3.97 | |
| 29 Apr 2022 | 10.62% | 5.05 |
See also: Evofem Biosciences, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.